Influence of bevacizumab, sunitinib and sorafenib as single agents or in combination on the inhibitory effects of VEGF on human dendritic cell differentiation from monocytes.
贝伐珠单抗、舒尼替尼和索拉非尼作为单一药物或联合用药对 VEGF 抑制人类单核细胞分化为树突状细胞的影响
期刊:British Journal of Cancer
影响因子:6.8
doi:10.1038/sj.bjc.6604965
Alfaro C, Suarez N, Gonzalez A, Solano S, Erro L, Dubrot J, Palazon A, Hervas-Stubbs S, Gurpide A, Lopez-Picazo J M, Grande-Pulido E, Melero I, Perez-Gracia J L
